Increase in processing power of AI systems leading to enhanced AI capabilities

-
The global artificial intelligence in medicines market was valued at $719 million in 2017 and is estimated to reach $18,119 million at a CAGR of 49.6% from 2018 to 2025. Artificial intelligence (AI) in medicine is used to analyze complex medical data by approximating human cognition with the help of algorithms and software. 


The development of novel pharmaceuticals and biologicals through clinical trials can take more than a decade and cost billions of dollars during that tenure period. AI technology can help to make this process faster and cheaper, which in turn is expected to help improve the efficiency of pharmaceutical and biotechnology companies.

 Product Type Segment Review

Based on the product type, the market is segmented into hardware, software, and service. The software segment occupied the highest share in 2017, owing to continuous software innovation that caters to the requirement in the healthcare sector. The hardware segment is projected to witness the highest growth rate during the forecast period.

Technology Segment Review

Based on technology, it is classified into deep learning, querying method, natural language processing, and context-aware processing. The natural language processing segment accounted for the highest share in 2017 as this technology infrequently used during various applications such as drug discovery and clinical trial identification.

Key Geographical Segment

As per region, the artificial intelligence in medicine market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in 2017 and is expected to retain its dominance throughout the forecast period owing to the availability of capital investments and an increase in adoption of AI technology.

The key players operating in the global artificial intelligence in medicine market include Welltok, Inc., Intel Corporation, Nvidia Corporation, Google Inc., IBM Corporation, Microsoft Corporation, General Vision, Inc., Enlitic, Inc., BioXcel Corporation, and Berg Health
.
Other prominent players in the value chain include InSilico Medicine, Inc., Globavir Biosciences, Inc., GNS Healthcare, Flatiron Health, Benevolent AI, Atomwise, Verge Genomics, Cloud Pharmaceuticals, and Recursion Pharmaceuticals.

Key Benefits for Stakeholders

This report entails a detailed quantitative analysis of the current market trends from 2017 to 2025 to identify the prevailing opportunities.
Market estimations are based on a comprehensive analysis of the key developments in the industry.
The global market is comprehensively analyzed with respect to product type, technology, application, and region.

In-depth analysis based on region assists to understand the regional market to assist in strategic business planning.
The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Artificial Intelligence in Medicine Market Key Segments:

By Product Type

Hardware
Software
Service

By Technology

Deep Learning
Querying Method
Natural Language Processing
Context-Aware Processing

By Application

Drug Discovery & Repurposing (Preclinical Phase)
Clinical Research Trial
Personalized Medicine
Others

For more inquiry contact our sales team at contact@aarkstore.com

Related Reports:

Global Artificial Intelligence Machine Market Research Report 2018

Global Artificial Intelligence Machine Market Research Report 2018

Global Artificial Intelligence Chip Market Research Report 2018

Contact Details:

Aarkstore Enterprise

Phone: +91 - 22 2756 4963
24/7 Online Support: +91 9987295242
Our website: https://www.aarkstore.com
Our blog: https://www.aarkstore.com/blog/

Comments

Post a Comment

Popular posts from this blog

India travels across!

-
Image
Tourism is a cultural and provisional base for any nation. India is democratic and has shown enormous growth trends in outbound tourism. Prevailing estimation proposes that India has moved up becoming the 8th largest outbound travel market destination of the world. India outbound tourism market has risen considerably in recent years, giving tremendous profits to tours and travel companies abroad. CULMINATION According to the research of India Travel and Tourism market , most of the major players of tourism business over the globe are looking to invest in the expenses of India's population. Thus, capitalizing the overall annual growth with outbound meetings, incentives, conferences, and exhibitions. The recent estimated value of India's travel business has reached a whopping 95-billion-dollar extension with the major push being the US. This data was released and evaluated greatly in compliance with the travel and tourism market reports from...
Read more

A detailed SWOT report on A.P. Moller – Maersk

-
Image
A.P. Moller - Maersk AS (MAERSK B) - Financial and Strategic SWOT Analysis The review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers, and competitors better. The profile contains critical company information including: ·         Business description – A detailed description of the company’s operations and business divisions. ·         Corporate strategy – Analyst’s summarization of the company’s business strategy. ·         SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities, and threats. · ...
Read more

Human Parainfluenza Virus 3 Infections, H1 2018

-
Image
Human parainfluenza virus 3 is a life-threatening infection that causes respiratory illnesses in infants and young children. Symptoms include fever, cough, runny nose, croup, bronchiolitis, wheezing and sore throat. Treatment includes over-the-counter medications for pain and fever. Scope The pipeline guide provides a snapshot of the global therapeutic landscape of Human Parainfluenza Virus 3 Infections (Infectious Disease). The pipeline guide reviews pipeline therapeutics for Human Parainfluenza Virus 3 Infections (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources. The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. The pipeline guide features descriptive drug profiles for the pipeline products which compris...
Read more